PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $927,000 | -72.7% | 13,225 | -76.7% | 0.01% | -75.0% |
| Q4 2020 | $3,391,000 | +26.4% | 56,667 | +27.0% | 0.02% | +17.6% |
| Q3 2020 | $2,682,000 | -33.6% | 44,616 | -42.0% | 0.02% | -34.6% |
| Q2 2020 | $4,037,000 | +56.5% | 76,944 | 0.0% | 0.03% | +44.4% |
| Q1 2020 | $2,580,000 | -26.0% | 76,944 | 0.0% | 0.02% | +12.5% |
| Q4 2019 | $3,486,000 | +19.0% | 76,944 | 0.0% | 0.02% | +14.3% |
| Q3 2019 | $2,929,000 | -12.5% | 76,944 | 0.0% | 0.01% | -6.7% |
| Q2 2019 | $3,346,000 | -14.2% | 76,944 | -24.9% | 0.02% | -11.8% |
| Q1 2019 | $3,901,000 | +443.3% | 102,488 | +513.7% | 0.02% | +466.7% |
| Q4 2018 | $718,000 | +2143.8% | 16,701 | +2655.9% | 0.00% | – |
| Q1 2016 | $32,000 | -75.9% | 606 | -67.7% | 0.00% | -100.0% |
| Q2 2015 | $133,000 | -20.4% | 1,879 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $167,000 | 0.0% | 1,879 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $167,000 | – | 1,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |